DOCK4 and lung cancer: Among the predicted targets, SASH1 and DOCK4, which have been implicated in lung cancer prognosis, are recognized as oncogenes in LUAD (Liu A. et al., 2024; Burgess et al., 2020; Altaf et al., 2023).